22-45518688-C-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_006486.3(FBLN1):c.86C>T(p.Ala29Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000474 in 1,603,486 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. A29A) has been classified as Likely benign.
Frequency
Consequence
NM_006486.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBLN1 | NM_006486.3 | c.86C>T | p.Ala29Val | missense_variant | Exon 2 of 17 | ENST00000327858.11 | NP_006477.3 | |
FBLN1 | NM_001996.4 | c.86C>T | p.Ala29Val | missense_variant | Exon 2 of 15 | NP_001987.3 | ||
FBLN1 | NM_006485.4 | c.86C>T | p.Ala29Val | missense_variant | Exon 2 of 15 | NP_006476.3 | ||
FBLN1 | NM_006487.3 | c.86C>T | p.Ala29Val | missense_variant | Exon 2 of 15 | NP_006478.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000258 AC: 6AN: 232240Hom.: 0 AF XY: 0.0000398 AC XY: 5AN XY: 125568
GnomAD4 exome AF: 0.0000503 AC: 73AN: 1451304Hom.: 0 Cov.: 32 AF XY: 0.0000458 AC XY: 33AN XY: 720886
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.86C>T (p.A29V) alteration is located in exon 2 (coding exon 2) of the FBLN1 gene. This alteration results from a C to T substitution at nucleotide position 86, causing the alanine (A) at amino acid position 29 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at